The aggressive biology of cancers arising in adolescent and young adult (AYA; ages 15–39 years) patients is thought to contribute to poor survival outcomes. Methods: We used clinical next-generation sequencing (NGS) results to examine the molecular alterations and diverse biology of cancer in AYA patients.

Authors: Vivek Subbiah, Manojkumar Bupathi, Shumei Kato1, Andrew Livingston, John Slopis, Pete M. Anderson, David S. Hong

Read full article